PALISADE CAPITAL MANAGEMENT, LP

Position in MRK — Merck & Co., Inc.

CIK 1009006 FORT LEE, NJ

Position in MRK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$258,799

+$16,535 QoQ

Shares Held

2,014

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#3,311

of 3,769 holders

Holding Since

Dec 2022

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

PALISADE CAPITAL MANAGEMENT, LP holds $44,577,032 across 7 Drug Manufacturers - General names. MRK ranks #7 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	70,905	$17,842,534
2	LLY	ELI LILLY & Co	12,084	$14,493,913
3	JNJ	Johnson & Johnson	23,321	$5,922,834
4	NVO	Novo Nordisk A S	113,575	$5,444,785
5	GILD	Gilead Sciences, Inc.	2,742	$346,424
6	AZN	Astrazeneca PLC	1,412	$267,743
7	MRK	Merck & Co., Inc. This page	2,014	$258,799

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$258,799	2,014	0.0%	Shares	Sole	2026-08-14
2026-03-31	$242,264	2,014	0.0%	Shares	Sole	2026-05-15
2025-12-31	$211,993	2,014	-22.3%	Shares	Sole	2026-02-17
2025-06-30	$205,103	2,591	+30.5%	Shares	Sole	2025-08-14
2024-09-30	$225,530	1,986	-32.4%	Shares	Sole	2024-11-14
2024-06-30	$363,476	2,936	-1.1%	Shares	Sole	2024-08-14
2024-03-31	$391,891	2,970	-11.7%	Shares	Sole	2024-05-15
2023-12-31	$366,525	3,362	0.0%	Shares	Sole	2024-02-14
2023-09-30	$346,117	3,362	0.0%	Shares	Sole	2023-11-14
2023-06-30	$387,941	3,362	+1.5%	Shares	Sole	2023-08-14
2023-03-31	$352,257	3,311	0.0%	Shares	Sole	2023-05-08
2022-12-31	$367,355	3,311	—	Shares	Sole	2023-03-24
No filing history on record for this holder in this stock.